P.16.3 DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles
暂无分享,去创建一个
F. Magdinier | G. Butler-Browne | V. Mouly | S. Sacconi | A. Vasiljevic | T. Attié-Bitach | P. Rameau | B. Bessières | V. Mariot | J. Dumonceaux | S. Whalen | M. Ferreboeuf | S. Roche | S. Collardeau | J. Robin-Ducellier
[1] Daniel G. Miller,et al. Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells. , 2013, Human molecular genetics.
[2] F. Magdinier,et al. Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy. , 2013, Human molecular genetics.
[3] L. Kunkel,et al. Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy. , 2013, Human molecular genetics.
[4] Yi-Wen Chen,et al. DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? , 2012, Journal of cellular and molecular medicine.
[5] Daniel G. Miller,et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2 , 2012, Nature Genetics.
[6] O. King,et al. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. , 2012, Human molecular genetics.
[7] F. Dilworth,et al. Turning on Myogenin in Muscle: A Paradigm for Understanding Mechanisms of Tissue-Specific Gene Expression , 2012, Comparative and functional genomics.
[8] Abraham P. Fong,et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. , 2012, Developmental cell.
[9] L. Santoro,et al. Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling , 2012, Journal of Medical Genetics.
[10] S. Wilton,et al. The FSHD Atrophic Myotube Phenotype Is Caused by DUX4 Expression , 2011, PloS one.
[11] M. Lacey,et al. Gene expression during normal and FSHD myogenesis , 2011, BMC Medical Genomics.
[12] S. Tapscott,et al. Immunodetection of human double homeobox 4. , 2011, Hybridoma.
[13] Rabi Tawil,et al. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. , 2011, Trends in molecular medicine.
[14] S. Harper,et al. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53‐dependent myopathy in vivo , 2011, Annals of neurology.
[15] M. Tarnopolsky,et al. Clinical features of facioscapulohumeral muscular dystrophy 2 , 2010, Neurology.
[16] Daniel G. Miller,et al. Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene , 2010, PLoS genetics.
[17] Daniel G. Miller,et al. A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy , 2010, Science.
[18] R. Wuebbles,et al. Testing the effects of FSHD candidate gene expression in vertebrate muscle development. , 2010, International journal of clinical and experimental pathology.
[19] M. Kimmel,et al. Conflict of interest statement. None declared. , 2010 .
[20] Daniel G. Miller,et al. RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. , 2009, Human molecular genetics.
[21] M. Kyba,et al. An isogenetic myoblast expression screen identifies DUX4‐mediated FSHD‐associated molecular pathologies , 2008, The EMBO journal.
[22] H. Qian,et al. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1 , 2007, Proceedings of the National Academy of Sciences.
[23] A. Rosa,et al. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein , 2007, Neuromuscular Disorders.
[24] N. Thomas,et al. A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere , 2006, Journal of Medical Genetics.
[25] R. Tawil,et al. Facioscapulohumeral muscular dystrophy , 2006, Muscle & nerve.
[26] R. Frants,et al. The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy. , 2005, American journal of human genetics.
[27] R. Frants,et al. Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy. , 2004, American journal of human genetics.
[28] L. Sandkuijl,et al. Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy. , 2004, American journal of human genetics.
[29] G. V. Ommen,et al. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere , 2002, Nature Genetics.
[30] Markus R Wenk,et al. Amphiphysin 2 (Bin1) and T-Tubule Biogenesis in Muscle , 2002, Science.
[31] H. Ding,et al. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. , 1999, Gene.
[32] R. Tupler,et al. Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. , 1996, Journal of medical genetics.
[33] J E Hewitt,et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. , 1993, Human molecular genetics.
[34] P Halonen,et al. [Facioscapulohumeral muscular dystrophy]. , 1990, Duodecim; laaketieteellinen aikakauskirja.